FDA Inspection
CSL Plasma, Inc.CSL Plasma, Inc. – FDA Inspection, Oct 23, 2009
Record Details
This FDA Inspection record concerns CSL Plasma, Inc., with an inspection on October 23, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma, Inc.
- Inspection Date
- October 23, 2009
- Product Type
- Biologics
View Company Profile
ID · 52145aec-92b2-4cc3-ac50-f96ebb0a756c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 626131
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 8, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 20, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 1, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma, Inc.
- FDA Inspection 1192781 - 2022-12-08
- FDA Inspection 1020879 - 2017-07-20
- FDA Inspection 913493 - 2015-02-06
- FDA Inspection 818345 - 2013-02-12
- FDA Inspection 740656 - 2011-09-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.